Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate pharmacokinetics, pharmacodynamics, safety and
potential for drug-drug interaction of arhalofenate when combined with febuxostat in adult
population with gout.